Hengbo Zhou

1.1k total citations
18 papers, 617 citations indexed

About

Hengbo Zhou is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Hengbo Zhou has authored 18 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Hengbo Zhou's work include Cancer Cells and Metastasis (12 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Hedgehog Signaling Pathway Studies (4 papers). Hengbo Zhou is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Hedgehog Signaling Pathway Studies (4 papers). Hengbo Zhou collaborates with scholars based in United States, France and Germany. Hengbo Zhou's co-authors include Heide L. Ford, Deepika Neelakantan, Timothy P. Padera, Pin‐Ji Lei, Michael T. Lewis, Rebecca L. Vartuli, Lingdi Zhang, Michael Oliphant, Meng-Fen Wu and Xiaomei Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Hengbo Zhou

17 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hengbo Zhou United States	12	357	268	154	97	75	18	617
Xuhong Fu China	12	488 1.4×	172 0.6×	137 0.9×	77 0.8×	87 1.2×	12	712
Agnieszka Martowicz Austria	14	282 0.8×	277 1.0×	157 1.0×	80 0.8×	60 0.8×	20	587
Viviana Vallacchi Italy	12	465 1.3×	277 1.0×	169 1.1×	158 1.6×	64 0.9×	25	679
Fabiana Lüönd Switzerland	7	380 1.1×	330 1.2×	237 1.5×	69 0.7×	95 1.3×	9	683
Lidia Moyano‐Galceran Sweden	12	265 0.7×	330 1.2×	155 1.0×	162 1.7×	86 1.1×	15	679
Veronica Veschi Italy	16	444 1.2×	266 1.0×	181 1.2×	114 1.2×	49 0.7×	26	701
Laura Gómez-Cuadrado United Kingdom	9	347 1.0×	392 1.5×	152 1.0×	159 1.6×	92 1.2×	9	745
Shaokun Shu United States	11	330 0.9×	208 0.8×	167 1.1×	108 1.1×	58 0.8×	18	575
Guoxin Mao China	17	511 1.4×	189 0.7×	221 1.4×	81 0.8×	83 1.1×	35	655
Dorcas A. Annan Japan	10	320 0.9×	235 0.9×	193 1.3×	180 1.9×	66 0.9×	14	574

Countries citing papers authored by Hengbo Zhou

Since Specialization

Citations

This map shows the geographic impact of Hengbo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengbo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengbo Zhou more than expected).

Fields of papers citing papers by Hengbo Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengbo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengbo Zhou. The network helps show where Hengbo Zhou may publish in the future.

Co-authorship network of co-authors of Hengbo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hengbo Zhou. A scholar is included among the top collaborators of Hengbo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengbo Zhou. Hengbo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Sabatier, Marie, Ani Solanki, Sangeetha Thangaswamy, et al.. (2025). Lymphatic collection and cell isolation from mouse models for multiomic profiling. Nature Protocols. 20(4). 884–901.

Nikmaneshi, Mohammad R., James W. Baish, Hengbo Zhou, Timothy P. Padera, & Lance L. Munn. (2023). Transport Barriers Influence the Activation of Anti‐Tumor Immunity: A Systems Biology Analysis. Advanced Science. 10(36). e2304076–e2304076. 4 indexed citations

Lei, Pin‐Ji, Ethel R. Pereira, Zohreh Amoozgar, et al.. (2023). Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes. The Journal of Experimental Medicine. 220(9). 35 indexed citations

Jones, Dennis, Zixiong Wang, Ivy Chen, et al.. (2022). Solid stress impairs lymphocyte infiltration into lymph node metastases. The FASEB Journal. 36(S1). 1 indexed citations

Jones, Dennis, Zixiong Wang, Ivy X. Chen, et al.. (2021). Solid stress impairs lymphocyte infiltration into lymph-node metastases. Nature Biomedical Engineering. 5(12). 1426–1436. 55 indexed citations

Zhou, Hengbo, Pin‐Ji Lei, & Timothy P. Padera. (2021). Progression of Metastasis through Lymphatic System. Cells. 10(3). 627–627. 74 indexed citations

Oliphant, Michael, Deguang Kong, Hengbo Zhou, Michael T. Lewis, & Heide L. Ford. (2020). Two Sides of the Same Coin: The Role of Developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasis. Journal of Mammary Gland Biology and Neoplasia. 25(2). 85–102. 11 indexed citations

Kong, Deguang, et al.. (2020). VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk. Oncogene. 40(5). 964–979. 64 indexed citations

Simbulan‐Rosenthal, Cynthia M., et al.. (2019). CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition. Journal of Oncology. 2019. 1–19. 16 indexed citations

10.

Vartuli, Rebecca L., Hengbo Zhou, Lingdi Zhang, et al.. (2018). Eya3 promotes breast tumor–associated immune suppression via threonine phosphatase–mediated PD-L1 upregulation. Journal of Clinical Investigation. 128(6). 2535–2550. 34 indexed citations

11.

Zhang, Lingdi, Hengbo Zhou, Xueni Li, et al.. (2018). Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression. Nature Communications. 9(1). 1047–1047. 61 indexed citations

12.

Neelakantan, Deepika, Hengbo Zhou, Michael Oliphant, et al.. (2017). EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells. Nature Communications. 8(1). 15773–15773. 130 indexed citations

13.

Simbulan‐Rosenthal, Cynthia M., Sivanesan Dakshanamurthy, Hong‐Bin Fang, et al.. (2017). The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma. Oncotarget. 8(8). 12576–12595. 44 indexed citations

14.

Zhou, Hengbo, Lingdi Zhang, Rebecca L. Vartuli, Heide L. Ford, & Rui Zhao. (2017). The Eya phosphatase: Its unique role in cancer. The International Journal of Biochemistry & Cell Biology. 96. 165–170. 26 indexed citations

15.

Zhou, Hengbo, Deepika Neelakantan, & Heide L. Ford. (2016). Clonal cooperativity in heterogenous cancers. Seminars in Cell and Developmental Biology. 64. 79–89. 47 indexed citations

16.

Zhou, Hengbo, et al.. (2015). Abstract 4224: CD133 knockdown sensitizes melanoma to kinase inhibitors. Cancer Research. 75(15_Supplement). 4224–4224. 1 indexed citations

17.

DiVito, Kyle A., Hengbo Zhou, Weiyi Zhang, et al.. (2015). Id3 induces an Elk‐1–caspase‐8‐dependent apoptotic pathway in squamous carcinoma cells. Cancer Medicine. 4(6). 914–924. 13 indexed citations

18.

Zhou, Hengbo, et al.. (2014). Abstract 3891: CD133 is associated with resistance of melanoma to multikinase inhibition. Cancer Research. 74(19_Supplement). 3891–3891. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact